PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
04-Jun-2020 VIVEbiotech collaborates with Xyphos Biosciences for clinical development support of convertibleCAR-T(TM) cell therapy Astellas Pharma Inc
04-Jun-2020 AbbVie at EULAR | New Long-term Data from RINVOQ™ (upadacitinib, 15 mg) Phase 3 Studies in Rheumatoid Arthritis AbbVie
04-Jun-2020 Genmab Announces European Marketing Authorization for the Subcutaneous Formulation of DARZALEX® (daratumumab) for the Treatment of Patients with Multiple Myeloma Genmab A/S
03-Jun-2020 NOVO VENTURES LEADS US$55M SERIES B INVESTMENT IN NODTHERA Novo Holdings A/S
03-Jun-2020 Ervaxx rebrands as Enara Bio to reflect a broader emphasis on the discovery and development of novel TCR-based cancer immunotherapies Enara Bio
03-Jun-2020 Oncodesign establishes strategic alliance with HitGen to strengthen its Integrated Drug Discovery Service (IDDS) named DRIVETM Oncodesign
03-Jun-2020 COVID-19: Swedish company is awarded prestigious grant GAEU Consulting AB
03-Jun-2020 Sarclisa® (isatuximab) approved for the treatment of relapsed/refractory multiple myeloma in the EU1 Sanofi
03-Jun-2020 Helsinn Group announces FDA approval of a new liquid formulation of AKYNZEO® (fosnetupitant/palonosetron) injection in the United States Lugano
03-Jun-2020 The Holistic Reports “Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020 The Holistic Report
03-Jun-2020 WORLD MEDICAL COMPOSITES MARKET By Fiber Type Overview And Forecast, 2018-2025. theholisticreports.
03-Jun-2020 Almac Clinical Technologies Introduces SimplifyTM, an Advanced IRT Solution Enabling Faster Clinical Trials Start-up Almac Clinical Technologies
03-Jun-2020 Orgenesis to collaborate with The Edith Wolfson Medical Center to conduct clinical study using Orgenesis’ proprietary POCare technologies for the generation and expansion of Tumor Infiltrating Lymphocytes Orgenesis Inc
03-Jun-2020 BIOQUELL HELPING PHARMACEUTICAL COMPANIES RESUME OPERATIONS POST COVID-19 BIOQUELL
03-Jun-2020 Celltrion announces positive pre-clinical results for COVID- 19 antiviral antibody treatment, showing improvement in recovery time Celltrion Healthcare
03-Jun-2020 Sanofi to present oncology strategy, provide update on portfolio and emerging pipeline Sanofi
03-Jun-2020 Santhera Announces Completion of ReveraGen’s Long-Term Extension Study with Vamorolone in Duchenne Muscular Dystrophy Santhera Pharmaceuticals
03-Jun-2020 AbbVie Submits Regulatory Applications to FDA and EMA for RINVOQ™ (upadacitinib) for the Treatment of Adults with Active Psoriatic Arthritis AbbVie
03-Jun-2020 ASCO 2020: UK-first study shows feasibility of genetic screening for prostate cancer The Institute of Cancer Research
03-Jun-2020 Sanofi to launch “Action 2020”, a worldwide employee stock purchase plan Sanofi